Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001823563-26-000013
Filing Date
2026-04-20
Accepted
2026-04-20 20:37:51
Documents
1
Period of Report
2026-04-20

Document Format Files

Seq Description Document Type Size
1 form4-04212026_120444.html 4  
1 form4-04212026_120444.xml 4 6590
  Complete submission text file 0001823563-26-000013.txt   8039
Mailing Address C/O VERACYTE, INC. 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Chambers Rebecca (Reporting) CIK: 0001823563 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-43235 | Film No.: 26876511

Mailing Address 47071 BAYSIDE PARKWAY FREMONT CA 94538
Business Address 47071 BAYSIDE PARKWAY FREMONT CA 94538 510-626-9888
Alamar Biosciences, Inc. (Issuer) CIK: 0002104204 (see all company filings)

EIN.: 364899036 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)